Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis

被引：0
|
作者：
Mieraf Taddesse Tolla
Ole Frithjof Norheim
Solomon Tessema Memirie
Senbeta Guteta Abdisa
Awel Ababulgu
Degu Jerene
Melanie Bertram
Kirsten Strand
Stéphane Verguet
Kjell Arne Johansson
机构：
[1] University of Bergen,Department of Global Public Health and Primary Health Care
[2] Addis Ababa University,Department of Internal Medicine, School of Medicine
[3] Federal Ministry of Health (FMOH),Department of Global Health and Population
[4] Management Science for Health,undefined
[5] World Health Organization,undefined
[6] Harvard T.H. Chan School of Public Health,undefined
来源：
Cost Effectiveness and Resource Allocation | / 14卷
关键词：
Cost-effectiveness analysis; Cardiovascular disease; Ischemic heart disease; Stroke; Prevention; Treatment; Ethiopia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A COMPUTER-SIMULATION MODEL FOR COST-EFFECTIVENESS ANALYSIS OF CARDIOVASCULAR-DISEASE PREVENTION
    JOHANNESSON, M
    HEDBRANT, J
    JONSSON, B
    [J]. MEDICAL INFORMATICS, 1991, 16 (04): : 355 - 362
  • [22] Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
    Torbjørn Wisløff
    Randi M Selmer
    Sigrun Halvorsen
    Atle Fretheim
    Ole F Norheim
    Ivar Sønbø Kristiansen
    [J]. BMC Cardiovascular Disorders, 12
  • [23] Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam
    Thi-Phuong-Lan Nguyen
    Wright, E. Pamela
    Thanh-Trung Nguyen
    Schuiling-Veninga, C. C. M.
    Bijlsma, M. J.
    Thi-Bach-Yen Nguyen
    Postma, M. J.
    [J]. PLOS ONE, 2016, 11 (05):
  • [24] Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly
    Lin, Liang
    Teng, Monica
    Zhao, Ying Jiao
    Khoo, Ai Leng
    Seet, Raymond Chee Seong
    Yong, Quek Wei
    Yeo, Tiong Cheng
    Lim, Boon Peng
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2015, 29 (02) : 187 - 197
  • [25] Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease
    Erickson, Kevin F.
    Japa, Sohan
    Owens, Douglas K.
    Chertow, Glenn M.
    Garber, Alan M.
    Goldhaber-Fiebert, Jeremy D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (12) : 1250 - 1258
  • [26] Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease
    Ferket, Bart S.
    Hunink, M. G. Myriam
    Khanji, Mohammed
    Agarwal, Isha
    Fleischmann, Kirsten E.
    Petersen, Steffen E.
    [J]. HEART, 2017, 103 (07) : 491 - 499
  • [27] Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study
    Linda J Cobiac
    Anne Magnus
    Jan J Barendregt
    Rob Carter
    Theo Vos
    [J]. BMC Public Health, 12
  • [28] COST-EFFECTIVENESS OF EICOSAPENTAENOIC ACID (EPA) ON PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE
    Kodera, S.
    Kiyosue, A.
    Ando, J.
    Komuro, I
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A614 - A614
  • [29] Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly
    Liang Lin
    Monica Teng
    Ying Jiao Zhao
    Ai Leng Khoo
    Raymond Chee Seong Seet
    Quek Wei Yong
    Tiong Cheng Yeo
    Boon Peng Lim
    [J]. Cardiovascular Drugs and Therapy, 2015, 29 : 187 - 197
  • [30] The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
    van Gils, Paul F.
    Over, Eelco A. B.
    Hamberg-van Reenen, Heleen H.
    de Wit, G. Ardine
    van den Berg, Matthijs
    Schuit, Albertine J.
    Engelfriet, Peter M.
    [J]. BMJ OPEN, 2011, 1 (02):
12345